FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg Recall

Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard t…

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Oct 31, 2018
Recall ID
D-0093-2019
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg starting Aug 24, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0093-2019 on Oct 31, 2018. Reason: CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient. Status: Terminated.

Why it was recalled

CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

Product description

Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00

Lot numbers, UPCs & expiration codes

Lot # B0438903-052118 70518-1220-00

Where it was sold

Product was distributed to a medical facility in South Carolina

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0093-2019
Classification
Class II
Status
Terminated
Recall initiated
Aug 24, 2018
FDA report date
Oct 31, 2018
Quantity
2 bottles of 90 tablets (180 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0093-2019, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
81395
Address
625 Kolter Dr Ste 4
Code information
Lot # B0438903-052118 70518-1220-00
Postal code
15701-3571
Report date
Oct 31, 2018
Product type
Drugs
Recall number
D-0093-2019
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
2 bottles of 90 tablets (180 tablets)
Termination date
Oct 29, 2018
Reason for recall
CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00
Distribution pattern
Product was distributed to a medical facility in South Carolina
Recall initiation date
Aug 24, 2018
Initial firm notification
Letter
Center classification date
Oct 24, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0093-2019, published Oct 31, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls